LOGIN TO YOUR ACCOUNT

Username
Password
Remember Me
Or use your Academic/Social account:

CREATE AN ACCOUNT

Or use your Academic/Social account:

Congratulations!

You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.

Important!

Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message

CREATE AN ACCOUNT

Name:
Username:
Password:
Verify Password:
E-mail:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Bhattarai, Bikash; Schmidt, Frances; Devkota, Ashok; Policard, Geraldine; Manhas, Saveena; Oke, Vikram; Agu, Chidozie Charles; Basunia, Md Rawshan; Enriquez, Danilo; Quist, Joseph; Kharel, Prakash (2015)
Publisher: Journal of Community Hospital Internal Medicine Perspectives
Journal: Journal of Community Hospital Internal Medicine Perspectives
Languages: English
Types: Article
Subjects: chyothorax/sarcoidosis; Lymphoscintigraphy; Lymphangioleiomyomatosis; Octreotide, Pulmonary Medicine
Obstruction of the thoracic duct may lead to accumulation of a lymphatic fluid rich in triglycerides named chyle. When chyle accumulates in the pleural cavity, it becomes a chylothorax. Malignancy, particularly lymphoma, is the most common cause of chylothorax; however, any pathology leading to obstruction or destruction of the thoracic duct can lead to a chylothorax. This particular case investigates an incidence of chylothorax in sarcoidosis. A 54-year-old African American woman with a medical history of sarcoidosis, congestive heart failure, and smoking presented to the emergency department with complaints of bilateral foot swelling and exertional shortness of breath 3 days in duration. Physical examination was positive for bilateral crepitations with decreased air entry, abdominal ascites, and bilateral 2+ pitting edema. Both chest X-ray and chest CT were positive for stable bilateral pleural effusions (when compared to imaging done 3 years previously), and thoracocentesis and paracentesis were positive for chylous fluid accumulation. Chylothorax was diagnosed, and based on the previous medical history, the lymphadenopathy of sarcoidosis was determined to cause the occlusion of the thoracic duct. Lymphoscintigraphy and surgical intervention were advised; however, the family decided on conservative management and the patient expired intubated in the ICU. Chylothorax is a rare manifestation of sarcoidosis and high index of suspicion should be there to diagnose this, as there is high morbidity and mortality associated with it.Keywords: chyothorax/sarcoidosis; Lymphoscintigraphy; Lymphangioleiomyomatosis; Octreotide(Published: 1 September 2015)Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 28300 - http://dx.doi.org/10.3402/jchimp.v5.28300
  • The results below are discovered through our pilot algorithms. Let us know how we are doing!

    • 1. McGrath EE, Blades Z, Anderson PB. Chylothorax: Aetiology, diagnosis and therapeutic options. Respir Med 2010; 104(1): 1 8.
    • 2. Soto-Martinez M, Massie J. Chylothorax: Diagnosis and management in children. Paediatr Respir Rev 2009; 10(4): 199 207.
    • 3. Nair SK, Petko M, Hayward MP. Aetiology and management of chylothorax in adults. Eur J Cardiothorac Surg 2007; 32(2): 362 9.
    • 4. Hillerdal G. Chylothorax and pseudochylothorax. Eur Respir J 1997; 10(5): 1157 62.
    • 5. Hooper C, Lee YC, Maskell N, BTS Pleural Guideline Group. Investigation of a unilateral pleural effusion in adults: British Thoracic Society Pleural Disease Guideline 2010. Thorax 2010; 65(Suppl 2): ii4 17.
    • 6. Huggins JT, Doelken P, Sahn SA, King L, Judson MA. Pleural effusions in a series of 181 outpatients with sarcoidosis. Chest 2006; 129(6): 1599 604.
    • 7. Soskel NT, Sharma OP. Pleural involvement in sarcoidosis. Curr Opin Pulm Med 2000; 6(5): 455 68.
    • 8. Romero S, Mart´ın C, Hernandez L, Verdu J, Trigo C, PerezMateo M, et al. Chylothorax in cirrhosis of the liver: Analysis of its frequency and clinical characteristics. Chest 1998; 114(1): 154 9.
    • 9. Van Renterghem DM, Pauwels RA. Chylothorax and pleural effusion as late complications of thoracic irradiation. Chest 1995; 108(3): 886 7.
    • 10. McWilliams A, Gabbay E. Chylothorax occurring 23 years post-irradiation: Literature review and management strategies. Respirology 2000; 5(3): 301 3.
    • 11. Runge T, Borbe´ly Y, Candinas D, Seiler C. Bilateral chylothorax following neck dissection: A case report. BMC Res Notes 2014; 7: 311.
    • 12. Ruggiero RP, Caruso G. Chylothorax a complication of subclavian vein catheterization. J Parenter Enteral Nutr 1985; 9(6): 750 3.
    • 13. Maldonado F, Hawkins FJ, Daniels CE, Doerr CH, Decker PA, Ryu JH. Pleural fluid characteristics of chylothorax. Mayo Clin Proc 2009; 84(2): 129 33.
    • 14. Skouras V, Kalomenidis I. Chylothorax: Diagnostic approach. Curr Opin Pulm Med 2010; 16(4): 387 93.
    • 15. Matsumoto T, Yamagami T, Kato T, Hirota T, Yoshimatsu R, Masunami T, et al. The effectiveness of lymphangiography as a treatment method for various chyle leakages. Br J Radiol 2009; 82(976): 286 90.
    • 16. Ogi S, Fukumitsu N, Uchiyama M, Mori Y. A case of chylothorax diagnosed by lymphoscintigraphy using Tc-99m HSA-DTPA. Clin Nucl Med 2002; 27(6): 455 6.
    • 17. Chalret du Rieu M, Mabrut JY. Management of postoperative chylothorax. J Visc Surg 2011; 148(5): e346 52.
    • 18. Takuwa T, Yoshida J, Ono S, Hishida T, Nishimura M, Aokage K, et al. Low-fat diet management strategy for chylothorax after pulmonary resection and lymph node dissection for primary lung cancer. J Thorac Cardiovasc Surg 2013; 146(3): 571 4.
    • 19. Kalomenidis I. Octreotide and chylothorax. Curr Opin Pulm Med 2006; 12(4): 264 7.
    • 20. Mares DC, Mathur PN. Medical thoracoscopic talc pleurodesis for chylothorax due to lymphoma: A case series. Chest 1998; 114(3): 731 5.
    • 21. Cho HJ, Kim DK, Lee GD, Sim HJ, Choi SH, Kim HR, et al. Chylothorax complicating pulmonary resection for lung cancer: Effective management and pleurodesis. Ann Thorac Surg 2014; 97(2): 408 13.
    • 22. Paul S, Altorki NK, Port JL, Stiles BM, Lee PC. Surgical management of chylothorax. Thorac Cardiovasc Surg 2009; 57(4): 226 8.
    • 23. Nadolski G, Itkin M. Thoracic duct embolization for the management of chylothoraces. Curr Opin Pulm Med 2013; 19(4): 380 6.
    • 24. Epaud R, Dubern B, Larroquet M, Tamalet A, Guillemot N, Maurage C, et al. Therapeutic strategies for idiopathic chylothorax. J Pediatr Surg 2008; 43(3): 461 5.
    • 25. Shimmyo T, Morita K, Mineshita M, Tagaya R, Ando K, Mochizuki A, et al. Pleuroperitoneal shunt for chylothorax and chylopericardium in lung cancer: A case report. Ann Thorac Cardiovasc Surg 2011; 17(1): 63 6.
  • No related research data.
  • Discovered through pilot similarity algorithms. Send us your feedback.

Share - Bookmark

Cite this article

Collected from